SC 13G/A: AMERIPRISE FINANCIAL INC

AI Summary

SC 13G/A filing by AMERIPRISE FINANCIAL INC.

Risk Assessment

Risk Level: low

Filing Documents

• d838097dsc13ga.htm (SC 13G/A) — 61KB
• d838097dex99i.htm (EX-99.I) — 1KB
• d838097dex99ii.htm (EX-99.II) — 4KB
• 0001193125-24-136030.txt ( ) — 68KB

From the Filing

SC 13G/A 1 d838097dsc13ga.htm SC 13G/A SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment #7 Under the Securities and Exchange Act of 1934 Eiger BioPharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 28249U204 (CUSIP Number) April 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: This Schedule is filed pursuant to Rule 13d-1(b) The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be CUSIP NO. 28249U105 1) Name of Reporting PersonAmeriprise Financial, Inc. S.S. or I.R.S. Identification No. of Above PersonIRS No. 13-3180631 2) Check the Appropriate Box if a Member of a Group (a)(b)* *This filing describes the reporting persons relationship with other persons, but the reporting person does not affirm the existence of a group. 3) SEC Use Only 4) Citizenship or Place of Organization Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5) Sole Voting Power 0 6) Shared Voting Power 0 7) Sole Dispositive Power 0 8) Shared Dispositive Power 0 9) Aggregate Amount Beneficially Owned by Each Reporting Person 0 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11) Percent of Class Represented by Amount In Row (9) 0.00% 12) Type of Reporting Person HC CUSIP NO. 28249U105 1) Name of Reporting PersonColumbia Management Investment Advisers, LLC S.S. or I.R.S. Identification No. of Above PersonIRS No. 41-1533211 2) Check the Appropriate Box if a Member of a Group (a)(b)* *This filing describes the reporting persons relationship with other persons, but the reporting person does not affirm the existence of a group. 3) SEC Use Only 4) Citizenship or Place of Organization Minnesota NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5) Sole Voting Power 0 6) Shared Voting Power 0 7) Sole Dispositive Power 0 8) Shared Dispositive Power 0 9) Aggregate Amount Beneficially Owned by Each Reporting Person 0 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11) Percent of Class Represented by Amount In Row (9) 0.00% 12) Type of Reporting Person IA CUSIP NO. 28249U105 1) Name of Reporting PersonColumbia Seligman Technology and Information Fund S.S. or I.R.S. Identification No. of Above PersonIRS No. 13-3154449 2) Check the Appropriate Box if a Member of a Group (a)(b)* *This filing describes the reporting persons relationship with other persons, but the reporting person does not affirm the existence of a group. 3) SEC Use Only 4) Citizenship or Place of Organization Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5) Sole Voting Power 0 6) Shared Voting Power 0 7) Sole Dispositive Power 0 8) Shared Dispositive Power 0 9) Aggregate Amount Beneficially Owned by Each Reporting Person 0 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11) Percent of Class Represented by Amount In Row (9) 0.00% 12) Type of Reporting Person IV 1(a) Name of Issuer: Eiger BioPharmaceuticals, Inc. 1(b) Address of Issuers Principal 2155 Park Boulevard Executive Offices: Palo Alto, CA 94306 2(a) Name of Person Filing: (a) Ameriprise Financial, Inc. (AFI) (b) Columbia Management Investment Advisers, LLC (CMIA) (c) Columbia Seligman Technology and Information Fund (Fund) 2(b) Address of Principal Business Office: (a) Ameriprise Financial, Inc. 145 Ameriprise Financial Center Minneapolis, MN 55474 (b) 290 Congress St. Boston, MA 02210 (c) 290 Congress Street Boston, MA 02210 2(c) Citizenship: (a) Delaware (b) Minnesota (c) Massachusetts 2(d) Title of Class of Securities: Common Stock 2(e) Cusip Number: 28249U204 3 Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b): (a) Ameriprise Financial, Inc. A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7) (b) Columbia Management Investment Advisers, LLC An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (c) Columbia Seligman Technology and Information Fund An investment company in accordance with Rule 13d-1(b)(1)(ii)(D). 4 Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person. CMIA and AFI do not directly own any shares of Common Stock of the issuer. As the investment adviser to the Fund and various other unregistered and regist

View Full Filing

View this SC 13G/A filing on SEC EDGAR